logo
AAT Bioquest

Cyluc1 [(4S)-2-(6,7-Dihydro-5H-thiazolo[4,5-f]indol-2-yl)-4,5-dihydro-thiazole-4-carboxylic acid]

Product Image
Product Image
Gallery Image 1
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Physical properties
Molecular weight305.37
SolventDMSO
Spectral properties
Correction Factor (260 nm)0.218
Correction Factor (280 nm)0.312
Extinction coefficient (cm -1 M -1)18231
Excitation (nm)362
Emission (nm)542
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
UNSPSC41105331

OverviewpdfSDSpdfProtocol


CAS
1247879-16-8
Molecular weight
305.37
Correction Factor (260 nm)
0.218
Correction Factor (280 nm)
0.312
Extinction coefficient (cm -1 M -1)
18231
Excitation (nm)
362
Emission (nm)
542
Cyluc1 is a synthetic cyclic alkylaminoluciferin that exhibits properties that are superior to those of D-luciferin for in vivo imaging due to its red-shifted luminescence. It binds to luciferase with higher affinity and and emits about 5.7-fold more light than aminoluciferin and 3.2-fold more light than D-luciferin. Its superior light output is maintained over a wide range (1-100 µM). It has been demonstrated that Cyluc1 readily crosses the blood-brain barrier in mice and provides much improved noninvasive bioluminescence imaging (BLI) of the brain at lower dose when compared to D-luciferin. It yields about 10-fold higher bioluminescent signal than D-luciferin when Luc2 luciferase expressing 4T1 breast cancer cells are implanted into the mammary fat pads of BABL/c mice. A rapid (4-5 min), long-lasting, and steady signal peak is observed following an i.v injection CycLuc1 in mice.

Calculators


Common stock solution preparation

Table 1. Volume of DMSO needed to reconstitute specific mass of Cyluc1 [(4S)-2-(6,7-Dihydro-5H-thiazolo[4,5-f]indol-2-yl)-4,5-dihydro-thiazole-4-carboxylic acid] to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.

0.1 mg0.5 mg1 mg5 mg10 mg
1 mM327.472 µL1.637 mL3.275 mL16.374 mL32.747 mL
5 mM65.494 µL327.472 µL654.943 µL3.275 mL6.549 mL
10 mM32.747 µL163.736 µL327.472 µL1.637 mL3.275 mL

Molarity calculator

Enter any two values (mass, volume, concentration) to calculate the third.

Mass (Calculate)Molecular weightVolume (Calculate)Concentration (Calculate)Moles
/=x=

Spectrum


Open in Advanced Spectrum Viewer
spectrum

Spectral properties

Correction Factor (260 nm)0.218
Correction Factor (280 nm)0.312
Extinction coefficient (cm -1 M -1)18231
Excitation (nm)362
Emission (nm)542

Images


References


View all 2 references: Citation Explorer
A synthetic luciferin improves in vivo bioluminescence imaging of gene expression in cardiovascular brain regions
Authors: Simonyan, H.; Hurr, C.; Young, C. N.
Journal: Physiol Genomics (2016): 762-770
Robust light emission from cyclic alkylaminoluciferin substrates for firefly luciferase
Authors: Reddy, G. R.; Thompson, W. C.; Miller, S. C.
Journal: J Am Chem Soc (2010): 13586-7